DelveInsight’s “Eosinophilic Esophagitis (EoE) Market“ report provides a thorough comprehension of the Eosinophilic Esophagitis, historical and forecasted epidemiology, and the Eosinophilic Esophagitis market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Eosinophilic Esophagitis market report also proffers an analysis of the current Eosinophilic Esophagitis treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the imperative takeaways of the Eosinophilic Esophagitis Market Research Report:
Get a sample copy of this report: Eosinophilic Esophagitis Market Size Landscape
Eosinophilic Esophagitis (EoE) represents a chronic, local immune-mediated oesophagal disease, characterized clinically by symptoms related to oesophagal dysfunction and histologically by eosinophil-predominant inflammation.
As per the estimates by DelveInsight, the total diagnosed Eosinophilic Esophagitis prevalent cases in 2020 were 547,924 cases. The highest prevalent cases were observed in the United States, accounting for approximately 58% of the total cases.
Eosinophilic Esophagitis Treatment Market
The Eosinophilic Esophagitis treatment involves Drugs, Diet, and Dilation. The first two components, which involve the use of proton pump inhibitors (PPIs), corticosteroids, immunosuppressant’s, and empirical diets or guided food elimination based on allergy tests, are more useful in the initial phases. In contrast, endoscopic dilation is reserved for oesophagal strictures.
Three dietary approaches for the management of EoE have emerged: the elemental diet, empiric dietary restrictions, and targeted dietary restrictions based on allergy testing.
PPIs are helpful as a first-line treatment for EoE patients. This therapy reduces acid production in the stomach and can reduce oesophagal inflammation. PPIs are recommended to be administered twice daily and continued for a minimum 2-month course after oesophagal eosinophilia is discovered. Afterwards, a repeat endoscopy with biopsies is performed to assess for persistent eosinophilic infiltration.
Eosinophilic Esophagitis Emerging Therapies Along with Key Players
Final thoughts on Eosinophilic Esophagitis Market Growth
Eosinophilic Esophagitis Market Drivers such as increasing awareness, the emergence of non-invasive modalities, identification of biomarkers, development of animal models are responsible for Market Growth. In contrast, Eosinophilic Esophagitis Market Barriers such as high cost of treatment, lack of multidisciplinary management, and lack of optimal endpoint for treatment will nosedive the market size.
Request for a Webex demo of the report @ Eosinophilic Esophagitis Treatment Market Size
Table of Contents
1
Eosinophilic Esophagitis (EoE) Key Insights
2
Eosinophilic Esophagitis Report Introduction
3
Eosinophilic Esophagitis Market Overview at a Glance
4
Eosinophilic Esophagitis Patient Split at a Glance
5
Executive Summary of Eosinophilic Esophagitis
6
Eosinophilic Esophagitis Disease Background and Overview
7
EoE Treatment
8
Guidelines for Management of EoE
9
Eosinophilic Esophagitis Epidemiology and Patient Population
9.1
The United States
9.2
EU5 Countries
9.2.1
Germany
9.2.2
France
9.2.3
Italy
9.2.4
Spain
9.2.5
The United Kingdom
9.3
Japan
10
Organizations contributing toward the fight against EoE
11
EoE Patient Journey
12
Case Report
13
Eosinophilic Esophagitis Marketed Drug
13.1
Jorveza: Dr Falk Pharma GmbH
14
Eosinophilic Esophagitis Emerging Drugs
14.1
Budesonide Oral Suspension: Takeda
14.2
Dupilumab: Regeneron Pharmaceuticals/Sanofi
14.3
Cendakimab: Bristol-Myers Squibb
14.4
APT-1011: Ellodi Pharmaceuticals
14.5
Benralizumab: AstraZeneca
14.6
Lirentelimab: Allakos
15
Other Promising Therapies
15.1
ESO-101: EsoCap AG
15.2
Etrasimod: Arena Pharmaceutical
15.3
Mepolizumab: GlaxoSmithKline
16
7MM Eosinophilic Esophagitis Market Analysis
16.1
The United States Eosinophilic Esophagitis Market Size
16.2
EU-5 Eosinophilic Esophagitis Market Size
16.2.1
Germany Market Size
16.2.2
France Market Size
16.2.3
Italy Market Size
16.2.4
Spain Market Size
16.2.5
The United Kingdom Market Size
16.3
Japan Eosinophilic Esophagitis Market Size
17
KOL Views
18
Eosinophilic Esophagitis Market Drivers
19
Eosinophilic Esophagitis Market Barriers
20
SWOT Analysis of Eosinophilic Esophagitis
21
Eosinophilic Esophagitis Unmet Needs
22
Appendix
23
DelveInsight Capabilities
24
Disclaimer
25
About DelveInsight
Browse full report with detailed TOC with charts, figures, tables @ Eosinophilic Esophagitis Market Share Report
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market